Abstract
The most important question in deciding which animal model to employ for a study on the efficacy of an antiarrhythmic agent concerns whether one is screening for a potential antiarrhythmic compound or is testing and evaluating an already proven antiarrhythmic agent. In “screening,” one may have hundreds of agents to analyze and therefore an inexpensive, simple and quick animal model is needed. However, if one is “testing” an already known antiarrhythmic agent then one must use more sophisticated animal models. An important criterion for any non-canine model employed in antiarrhythmic testing is that the model have some direct relationship to the human clinical situation. For example, the antivivisectionists have suggested that tissue cultures of cardiac cells should be utilized for evaluation of antiarrhythmic agents and indeed one can record cardiac pacemaker activity, and even simulated reentry by growing a circuit loop of tissue cultured cardiac cells. Although it is possible to do tissue culture studies on the effects of antiarrhythmic agents, I still believe there are questions as to the relevance of such studies to the clinical situation in man.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
W.F. Lubbe, P.S. Daries and L.H. Opie. Ventricular arrhythmias associated with coronary artery occlusion and reperfusion in the isolated perfused rat heart: a model for assessment of antifibrillatory action of antiarrhythmic agents. Cardiovasc. Res. 12:212–220, 1978.
Spear, J.F. Relationship between the scaler electrocardiogram and cellular electrophysiology of the rat heart. In: International Workshop on the Rat Electrocardiogram in acute and chronic pharmacology and toxicology. R. Budden, D.K. Detweiler and G. Zbinden (Eds.), in press, 1981.
Moore, E.N., Spear, J.F., Feldman, H.S., Moller, R. Electrophysiological properties of a new antiarrhythmic drug — Tocainide. Am. J. Physiol. 41:703, 1978.
Simson, M.B., Harden, W.R., Barlow, C.H., Harken, A.H. Epicardial ischemia as delineated with epicardial ST segment mapping and nicotainamide adenine dinucleotide (NADH) fluorescence photography. Am. J. Cardiol. 44:263, 1979.
Myerburg, R.J., Gelband, H., Nilsson, A., Sung, R.J., Thurer, R.J., Morales, A.R., Bassett, A.L. Long-term electrophysiological abnormalities resulting from experimental myocardial infarction in the cat. Circ. Res. 41:738, 1977.
Horowitz, L.N., Spear, J.F., Josephson, M.E., Kastor, J.A., MacVaugh, H., Moore, E.N. Ventricular fibrillation threshold in man. Am. J. Physiol. 39:274, 1977.
Lee, K.T., Lee, W.M., Han, J., Jarmolych, J., Bishop, M.B., and Goel, B.G. Experimental model for study of “sudden death” from ventricular fibrillation of asystole. Am. J. Cardiol. 32:62, 1973.
Janse, M.J., van Capelle, F.J.L., Morsink, H., Kleber, A.G., Wills-Schopman, F., Cardinale, R., Naumann, e, Alnoncourt, C. and Durrer, D. Flow of injury current in pattern of excitation during early ventricular arrhythmias and acute regional myocardial ischemia in isolated porcine and canine hearts: evidence for two different arrhythmogenic mechanisms. Circ. Res. 47:151, 1980.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Martinus Nijhojf Publishers bv, The Hague.
About this chapter
Cite this chapter
Moore, E.N., Spear, J.F., Michelson, E.L. (1981). Non-Canine Animal Models for Evaluating Antiarrhythmic Efficacy. In: Morganroth, J., Moore, E.N., Dreifus, L.S., Michelson, E.L. (eds) The Evaluation of New Antiarrhythmic Drugs. Developments in Cardiovascular Medicine, vol 11. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8270-3_5
Download citation
DOI: https://doi.org/10.1007/978-94-009-8270-3_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-8272-7
Online ISBN: 978-94-009-8270-3
eBook Packages: Springer Book Archive